Status:
COMPLETED
Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Safety.
Lead Sponsor:
Sanofi
Conditions:
Hygiene
Eligibility:
FEMALE
10-20 years
Phase:
PHASE3
Brief Summary
To prove the safety in normal conditions of use.
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Integral skin test in the region;
- Use of cosmetic product of the same category;
- Willingness in following the study procedures and to be present in the clinic at the days and scheduled time;
- Exclusion criteria:
- Lactation or gestational risk or gestation;
- Use of Anti-inflammatory, immunosuppression or anti-histaminic drugs;
- Atopic antecedent or allergic to cosmetic product;
- Active cutaneous disease in the evaluation area;
- Diseases which cause immunology decrease, such as diabetes and HIV;
- Endocrinal pathologies;
- Intense solar exposure 15 days before the evaluation;
- Treatment until four months before the selection
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Exclusion
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00785850
Start Date
August 1 2008
Last Update
March 6 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-Aventis Administrative Office
São Paulo, Brazil